Updating a quality-of-life survey for ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study is updating a questionnaire that measures how ovarian cancer affects your daily life. By sharing your experiences, you can help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ovarian cancer at any stage (localized or advanced).
- You are 18 years or older.
- You can read and understand the language of the questionnaire.
- You are willing to fill out questionnaires about your quality of life.
- You do not have significant cognitive impairment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This trial is a survey to understand the needs of people diagnosed with ovarian cancer. By participating, you can help shape better care and support for others.
This trial tests whether using a patient-reported outcomes tool can help manage fatigue during treatment for ovarian cancer. It aims to improve how you feel during therapy.
This trial studies how patients’ day-to-day quality of life changes after a specific type of rectal/low anterior resection during treatment for advanced ovarian cancer. It may help the medical team understand what symptoms and recovery needs to expect after surgery.
This study aims to improve care for ovarian cancer by including people at different stages: those being checked for it, those with known risk factors, and those who are generally healthy. It could help researchers better understand and support patients and their families.
This study looks at the real-world experiences of patients with ovarian cancer, whether newly diagnosed or with persistent or recurrent disease. It aims to learn more about the disease and its treatment over time.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.